Evidence map›Paper›PMID 35879293›Full record

ArticleJournal of microbiology and biotechnology2022

Molecular Cloning and Characterization of a Novel Exo-β-1,3-Galactanase from

Tong Zhou, Yanbo Hu, Xuecui Yan, Jing Cui, Yibing Wang, Feng Luo, Ye Yuan, Zhenxiang Yu, Yifa Zhou

Open access · bronzeAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of microbiology and biotechnology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.8field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 5 citations in OpenAlex.

  1. β-galactanase: an effective tool for the degradation of plant β-ᴅ-galactan.World journal of microbiology & biotechnology · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Tong ZhouDepartment of Endocrinology and Metabolism, Department of Respiratory Medicine, The First Hospital of Jilin University, Changchun 130021, P.R. China.
Yanbo HuSchool of Food Sciences and Engineering, Chang Chun University, Changchun 130022, P.R. China.
Xuecui YanEngineering Research Center of Glycoconjugates, Ministry of Education, Jilin Provincial Key Laboratory of Chemistry and Biology of Changbai Mountain Natural Drugs, School of Life Sciences, Northeast Normal University, Changchun, P.R. China.
Jing CuiCentral Laboratory, Changchun Normal University, Changchun Jilin province, P.R. China.
Yibing WangEngineering Research Center of Glycoconjugates, Ministry of Education, Jilin Provincial Key Laboratory of Chemistry and Biology of Changbai Mountain Natural Drugs, School of Life Sciences, Northeast Normal University, Changchun, P.R. China.
Feng LuoEngineering Research Center of Glycoconjugates, Ministry of Education, Jilin Provincial Key Laboratory of Chemistry and Biology of Changbai Mountain Natural Drugs, School of Life Sciences, Northeast Normal University, Changchun, P.R. China.
Ye YuanEngineering Research Center of Glycoconjugates, Ministry of Education, Jilin Provincial Key Laboratory of Chemistry and Biology of Changbai Mountain Natural Drugs, School of Life Sciences, Northeast Normal University, Changchun, P.R. China.
Zhenxiang YuDepartment of Endocrinology and Metabolism, Department of Respiratory Medicine, The First Hospital of Jilin University, Changchun 130021, P.R. China.
Yifa ZhouEngineering Research Center of Glycoconjugates, Ministry of Education, Jilin Provincial Key Laboratory of Chemistry and Biology of Changbai Mountain Natural Drugs, School of Life Sciences, Northeast Normal University, Changchun, P.R. China.
Northeast Normal University · CNFirst Hospital of Jilin University · CNChangchun Normal University · CNChangchun University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Arabinogalactans have diverse biological properties and can be used as pharmaceutical agents. Most arabinogalactans are composed of β-(1→3)-galactan, so it is particularly important to identify β-1,3-galactanases that can selectively degrade them. In this study, a novel exo-β-1,3-galactanase, named PoGal3, was screened from

Indexed as

Glycoside HydrolasesPenicilliumCloning, MolecularGalactansSubstrate SpecificityGalactansGlycoside HydrolasesExo-β-1,3-galactanaseglycoside hydrolase family 43larch wood arabinogalactansPenicillium oxalicum

Identifiers

PMID35879293
PMCPMC9628948
OpenAlexW4287842888

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.